75 related articles for article (PubMed ID: 18069394)
1. [Growth factors in chronic hepatitis C].
Panasiuk A; Pogorzelska J; Prokopowicz D
Przegl Epidemiol; 2007; 61(3):559-66. PubMed ID: 18069394
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS
J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y
Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727
[TBL] [Abstract][Full Text] [Related]
4. Selected apoptotic markers in serum of patients with chronic viral hepatitis C.
Głowacki MK; Cieśla A; Cibor D; Owczarek D; Mach T; Wiliński J; Wiliński B
Przegl Lek; 2014; 71(7):369-73. PubMed ID: 25338331
[TBL] [Abstract][Full Text] [Related]
5. Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.
Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
Hepatogastroenterology; 2008; 55(85):1400-3. PubMed ID: 18795698
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
Knobler H; Zhornicky T; Sandler A; Haran N; Ashur Y; Schattner A
Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
[TBL] [Abstract][Full Text] [Related]
7. Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C.
Jonsson JR; Barrie HD; O'Rourke P; Clouston AD; Powell EE
Hepatology; 2008 Jul; 48(1):80-7. PubMed ID: 18571785
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocytes growth factor (HGF), leptin, neopterin serum concentrations in patients with chronic hepatitis C].
Zwirska-Korczala K; Dziambor AP; Wiczkowski A; Berdowska A; Gajewska K; Stolarz W
Przegl Epidemiol; 2001; 55 Suppl 3():164-9. PubMed ID: 11984946
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
10. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
[TBL] [Abstract][Full Text] [Related]
11. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
12. Correlations among the serum levels of some interleukins and the histopathological aspects in chronic viral hepatitis C.
Avrămescu CS; Comănescu V; Popescu SN; Turculeanu A; Bălăşoiu M; Popescu CF; Lungulescu M
Rom J Morphol Embryol; 2008; 49(1):57-62. PubMed ID: 18273504
[TBL] [Abstract][Full Text] [Related]
13. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
[TBL] [Abstract][Full Text] [Related]
15. Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity.
Talaat RM
Viral Immunol; 2010 Apr; 23(2):151-7. PubMed ID: 20373995
[TBL] [Abstract][Full Text] [Related]
16. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
17. Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis.
Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
Hepatogastroenterology; 2008; 55(85):1439-44. PubMed ID: 18795707
[TBL] [Abstract][Full Text] [Related]
18. Serum apoptosis markers in acute liver failure: a pilot study.
Rutherford AE; Hynan LS; Borges CB; Forcione DG; Blackard JT; Lin W; Gorman AR; Shaikh OS; Reuben A; Harrison E; Reddy KR; Le WM; Chung RT;
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1477-83. PubMed ID: 17967565
[TBL] [Abstract][Full Text] [Related]
19. Intestine as source of cytokines and growth factors.
Porowski D; Niemczyk M; Ziółkowski J; Mucha K; Foroncewicz B; Nowak M; Pacholczyk M; Chmura A; Paczek L
Transplant Proc; 2009 Oct; 41(8):2989-91. PubMed ID: 19857658
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
